Page 14 - ஸ்ட்ராஸ்பர்க் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alentis Therapeutics: Alentis Founder Receives Prestigious French Academy of Science Award Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading authority in the field, has been awarded the Mémain-Pelletier, French Academy of Science award for his ground-breaking research into understanding the pathogenesis of liver cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201222005253/en/ Professor Thomas Baumert, founder of Alentis Therapeutics. Copyright Alentis Therapeutics Said Prof. Thomas Baumert: It s a great honor and a mark of recognition for my team, my colleagues and collaborators, some 50 in all. Now we are going to have to redouble our efforts, with a view to bringing our research to patients so they can truly benefit.

United statesKostenloser wertpapierhandelRoberto iaconePureos bioventuresNathalie grafSchroder adveqThomas baumertUniversity of strasbourgStrasbourg university hospitalInserm research institute for viralNational institutes of healthLaboratory of excellenceHarvard medical schoolLiver diseases branchFrench academy of scienceInstitute of harvard